RegeneronOfficial website ↗Learn about Regeneron’s mission to use the power of science to bring new medicines to patients… over and over again. Source: https://www.regeneron.com/about1 medicine explainedcemiplimabLibtayoPD-1 checkpoint inhibitorLibtayo (cemiplimab) is a PD-1 checkpoint inhibitor from Regeneron. By releasing exhausted T cells from the PD-1 brake, it restores immune attack on cancer cells and is used in advanced skin cancers and, with chemotherapy, in non-small cell lung cancer.T cells can recognise and kill cancer, but many tumours switch them off through a receptor called PD-1. Cemiplimab is an antibody that blocks PD-1 on
